HOME >> BIOLOGY >> NEWS
LA BioMed Medical/Research Briefs, July/August 2004

  • LA BioMed Supports Stem Cell Initiative
  • Ethnic Breast Cancer?
  • A Periodic Table For Biology

    La BioMed Supports Stem Cell Initiative

    In coalition with major health and business groups throughout California, LA BioMed has indicated its support for the California Stem Cell Bond Issue Initiative that recently qualified for November's ballot. The initiative will allocate money from a $3 billion bond to fund promising, California-based stem cell research.

    The initiative will distribute an average of $295 million per year over a 10-year period to fund stem cell research at California's universities and other advanced medical research facilities. It will fund all aspects of stem cell therapy development from basic research through clinical trials to the actual delivery of therapies to patients.

    Kenneth P. Trevett, President and CEO of LA BioMed, recently issued the following statement about the initiative:

    The stem cell initiative is a necessary step in the pursuit of scientific research because federal funding for stem cell research has been limited. Unquestionably, stem cell therapy is potentially the most important medical advance since the discovery of antibiotics. This critically important statewide initiative closes the federal funding gap and sets a new state model for advancing scientific research. From an economic standpoint, California will benefit from patents and royalties that result from the research. Construction of research facilities and new research jobs will generate millions of dollars in new tax revenues for California. More importantly, if stem cell research results in a single cure that reduces healthcare costs by just one percent, it would pay for itself several times over during the following decade and save lives along the way.

    Mr. Trevett is available to speak the merits of the stem cell initiative. To contact him, telephone or e-mail the Communicatio
    '"/>



  • Contact: David Feuerherd
    df@issuesmanagement.com
    310-215-0234
    Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
    30-Jul-2004


    Page: 1 2 3

    Related biology news :

    1. BioMed Central to consult funders and librarians over Open Access payment model
    2. BioMed Central explodes Open Access myths
    3. The Scientist and BioMed Central come together to publish high-impact magazine
    4. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
    5. BioMed Central to deposit e-journals with the British Library
    6. BioMed Central to consider charging authors for paper submissions
    7. Get Research on the move with BioMed Central
    8. BioMed Central to launch at microbiology meeting
    9. BioMed Central to free scientists and clinical researchers from copyright restrictions

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/2/2019)... ... January 31, 2019 , ... Through its ... microbiome research support in study design, planning, sample collection, and analysis to researchers ... and Gynecology, and Dr. Sara Vaughn, MD, Reproductive Endocrinology and Infertility Fellow, to ...
    (Date:2/2/2019)... ... February 01, 2019 , ... uBiome, the leader in ... A2LA, which establishes requirements for medical laboratories to demonstrate competence to deliver timely, ... as well as College of American Pathologists (CAP)-accredited, a designation given to the ...
    (Date:1/25/2019)... ... January 24, 2019 , ... uBiome, the ... Professor of Microbiology at the Jackson Laboratory (JAX), to its Scientific Advisory Board. ... Oh will bring to uBiome expertise in skin microbial interactions and probiotic treatments ...
    Breaking Biology News(10 mins):
    (Date:1/30/2019)... Rico (PRWEB) , ... January 29, 2019 , ... K&R ... the featured expert at a special online event titled: Six Ways to Shorten ... p.m. eastern time, February 13, 2019 on the BrightTALK network. , Negotiation expert ...
    (Date:1/28/2019)... ... 2019 , ... Fragment-based lead discovery (FBLD) involves biophysical screening ... false positives can be problematic due to high levels of solvents and nonspecific ... highly sensitive to detect weak interactions. Nanomed , leading producer of graphene ...
    (Date:1/21/2019)... FRANKLIN, Wis. (PRWEB) , ... January 21, 2019 ... ... company, announced their newest product line, SporActiv™, for the industrial and institutional cleaning ... a variety of residential and commercial cleaning needs. Applications include odor control, floor ...
    (Date:1/20/2019)... ... January 17, 2019 , ... TrakCel, the leading cell and ... Life Science Group (Quick Healthcare and QuickSTAT) today announce a partnership to offer ... and gene therapy industry to track products and manage the logistical processes of ...
    Breaking Biology Technology:
    Cached News: